Thyroid Cancer Clinical Trials in Georgia

Cancer Type = Thyroid Cancer

Cancer Type = Thyroid Cancer

There are currently 3 active Thyroid Cancer clinical trials in Georgia.
1.
A Phase 1 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors, Including RET-Fusion Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, and Other Tumors With Increased RET Activity
Cancer Type
Colon/Rectal Cancer, Lung Cancer, Skin Cancer (Non-Melanoma), Thyroid Cancer, Unknown Primary
NCI ID
NCT03157128
Protocol IDs
LOXO-RET-17001
NCI-2017-00976
2017-000800-59
2.
A Phase 2 Study of Lenvatinib in Combination with Radioactive Iodine Therapy in Patients with Progressive RAI-Sensitive Differentiated Thyroid Cancer
Cancer Type
Thyroid Cancer
NCI ID
NCT03506048
Protocol IDs
Winship4271-18
NCI-2018-00144
IRB00101617
3.
An Open Label Phase II Study of Tipifarnib in Advanced Non-Hematological Malignancies With HRAS Mutations
Cancer Type
Thyroid Cancer
NCI ID
NCT02383927
Protocol IDs
KO-TIP-001
NCI-2015-01835
NCI-2015-00949
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.